The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Tramatab 50 mg chewable tablets for dogs



CP-Pharma Handelsgesellschaft mbHVPA10810/031/002

Main Information

Trade NameTramatab 50 mg chewable tablets for dogs
Active SubstancesTramadol hydrochloride
Dosage FormTablet
Licence HolderCP-Pharma Handelsgesellschaft mbH
License Holder AddressOstlandring 13
31303 Burgdorf
Germany
Licence NumberVPA10810/031/002

Group Information

ATC CodeQN02AX02 tramadol
Therapeutic ClassNeurological Preparations
SpeciesDogs

Status

License statusAuthorised
Licence Issued02/02/2024
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back